CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 216 of 1
Non-Antibody Products
Page 216 of 1,288
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| CAY10795 | A 15-PGDH inhibitor (IC50 = 3 nM); increases PGE2 levels >3-fold in IL-1&b… | 5 mg | 37981-5 | More Info |
| CAY10796 | An inhibitor of GSK3 (34% inhibition when used at a concentration of 2.5 &… | 1 mg | 21190-1 | More Info |
| CAY10796 | An inhibitor of GSK3 (34% inhibition when used at a concentration of 2.5 &… | 5 mg | 21190-5 | More Info |
| CAY10796 | An inhibitor of GSK3 (34% inhibition when used at a concentration of 2.5 &… | 500 µg | 21190-500 | More Info |
| CAY10799 | A precursor in the synthesis of PSMA ligands and fluorescent probes | 1 mg | 39619-1 | More Info |
| CAY10799 | A precursor in the synthesis of PSMA ligands and fluorescent probes | 10 mg | 39619-10 | More Info |
| CAY10799 | A precursor in the synthesis of PSMA ligands and fluorescent probes | 5 mg | 39619-5 | More Info |
| CAY17c | An inhibitor of BRD4 and class I and class IIb HDACs; inhibits BRD4 (IC50… | 1 mg | 31077-1 | More Info |
| CAY17c | An inhibitor of BRD4 and class I and class IIb HDACs; inhibits BRD4 (IC50… | 5 mg | 31077-5 | More Info |
| CAY10723 (hydrochloride) | A PAD2 inhibitor (EC50 = 9.5 µM in a cellular target engagement assa… | 1 mg | 38018-1 | More Info |
| CAY10723 (hydrochloride) | A PAD2 inhibitor (EC50 = 9.5 µM in a cellular target engagement assa… | 5 mg | 38018-5 | More Info |
| CAY10723 (hydrochloride) | A PAD2 inhibitor (EC50 = 9.5 µM in a cellular target engagement assa… | 500 µg | 38018-500 | More Info |
| CAY10740 (hydrochloride) | An analog of GSK484; decreases the viability of 4T1 cells by 85 and 98% at… | 1 mg | 28320-1 | More Info |
| CAY10740 (hydrochloride) | An analog of GSK484; decreases the viability of 4T1 cells by 85 and 98% at… | 10 mg | 28320-10 | More Info |
| CAY10740 (hydrochloride) | An analog of GSK484; decreases the viability of 4T1 cells by 85 and 98% at… | 5 mg | 28320-5 | More Info |
| CAY10740 (hydrochloride) | An analog of GSK484; decreases the viability of 4T1 cells by 85 and 98% at… | 500 µg | 28320-500 | More Info |
| Caylin-1 | A nutlin-3 analog; inhibits the growth of HCT116 cells at high concentrati… | 1 mg | 10004985-1 | More Info |
| Caylin-1 | A nutlin-3 analog; inhibits the growth of HCT116 cells at high concentrati… | 10 mg | 10004985-10 | More Info |
| Caylin-1 | A nutlin-3 analog; inhibits the growth of HCT116 cells at high concentrati… | 5 mg | 10004985-5 | More Info |
| Caylin-2 | A nutlin-3 analog; inhibits the growth of HCT116 cells at high concentrati… | 1 mg | 10005002-1 | More Info |
| Caylin-2 | A nutlin-3 analog; inhibits the growth of HCT116 cells at high concentrati… | 10 mg | 10005002-10 | More Info |
| Caylin-2 | A nutlin-3 analog; inhibits the growth of HCT116 cells at high concentrati… | 5 mg | 10005002-5 | More Info |
| Cayman LipiDOT Strips™ - Developing Chamber | Cayman LipiDOT Strips™ - Developing Chamber can be used with Cayman… | 1 ea | 39380-1 | More Info |
| Cayman LipiDOT Strips™ - PIPs Plus | A simple tool for rapid identification of protein-lipid interactions; cont… | 2 ea | 38924-12 | More Info |
| Cayman Practice ELISA Kit | This assay has been developed for researchers that do not have experience… | 96 Well | 10009658-96WELLS | More Info |
| CAY10799 (potassium salt) | A derivative of oudenone; undergoes pH-dependent spontaneous cyclization t… | 1 mg | 40227-1 | More Info |
| CAY10729 (trifluoroacetate salt) (technical grade) | A tetrazole derivative of Cl-amidine; selectively inhibits PAD1 over PAD2,… | 1 mg | 26546-1 | More Info |
| CAY10729 (trifluoroacetate salt) (technical grade) | A tetrazole derivative of Cl-amidine; selectively inhibits PAD1 over PAD2,… | 5 mg | 26546-5 | More Info |
| CAY10729 (trifluoroacetate salt) (technical grade) | A tetrazole derivative of Cl-amidine; selectively inhibits PAD1 over PAD2,… | 500 µg | 26546-500 | More Info |
| CB-096 | An inhibitor of RAN translation; selectively binds to r(G4C2)8 (EC50 = 19… | 10 mg | 36407-10 | More Info |
| CB-096 | An inhibitor of RAN translation; selectively binds to r(G4C2)8 (EC50 = 19… | 100 mg | 36407-100 | More Info |
| CB-096 | An inhibitor of RAN translation; selectively binds to r(G4C2)8 (EC50 = 19… | 250 mg | 36407-250 | More Info |
| CB-096 | An inhibitor of RAN translation; selectively binds to r(G4C2)8 (EC50 = 19… | 50 mg | 36407-50 | More Info |
| CB-103 | An inhibitor of Notch signaling; binds to the BTD domain of RBPJ and inhib… | 1 g | 36293-1 | More Info |
| CB-103 | An inhibitor of Notch signaling; binds to the BTD domain of RBPJ and inhib… | 100 mg | 36293-100 | More Info |
| CB-103 | An inhibitor of Notch signaling; binds to the BTD domain of RBPJ and inhib… | 250 mg | 36293-250 | More Info |
| CB-103 | An inhibitor of Notch signaling; binds to the BTD domain of RBPJ and inhib… | 500 mg | 36293-500 | More Info |
| CB-1158 | An arginase inhibitor (IC50s = 0.086 and 0.296 µM for human arginase… | 1 mg | 27297-1 | More Info |
| CB-1158 | An arginase inhibitor (IC50s = 0.086 and 0.296 µM for human arginase… | 5 mg | 27297-5 | More Info |
| CB-1158 | An arginase inhibitor (IC50s = 0.086 and 0.296 µM for human arginase… | 500 µg | 27297-500 | More Info |
| CB-13 | A dual agonist of the CB1 (IC50 = 15 nM) and CB2 (IC50 = 98 nM) receptors;… | 10 mg | 10010398-10 | More Info |
| CB-13 | A dual agonist of the CB1 (IC50 = 15 nM) and CB2 (IC50 = 98 nM) receptors;… | 25 mg | 10010398-25 | More Info |
| CB-13 | A dual agonist of the CB1 (IC50 = 15 nM) and CB2 (IC50 = 98 nM) receptors;… | 5 mg | 10010398-5 | More Info |
| CB-13 | A dual agonist of the CB1 (IC50 = 15 nM) and CB2 (IC50 = 98 nM) receptors;… | 50 mg | 10010398-50 | More Info |
| CB-1954 | An antitumor prodrug that in rats is reduced by NQO1 to a bifunctional alk… | 1 mg | 21023-1 | More Info |
| CB-1954 | An antitumor prodrug that in rats is reduced by NQO1 to a bifunctional alk… | 10 mg | 21023-10 | More Info |
| CB-1954 | An antitumor prodrug that in rats is reduced by NQO1 to a bifunctional alk… | 25 mg | 21023-25 | More Info |
| CB-1954 | An antitumor prodrug that in rats is reduced by NQO1 to a bifunctional alk… | 5 mg | 21023-5 | More Info |
| CB-25 | A stable analog of Δ9-THC; exhibits high affinity for the CB1 and CB… | 1 mg | 10010116-1 | More Info |
| CB-25 | A stable analog of Δ9-THC; exhibits high affinity for the CB1 and CB… | 10 mg | 10010116-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile